全球血液和血液成分市場

2030年，全球血液和血液成分市場規模將達到148億美元

全球血液及血液成分市場規模預計在2024年為130億美元，預計到2030年將達到148億美元，2024年至2030年的複合年成長率為2.2%。血液成分是本報告分析的細分市場之一，預計其複合年成長率為2.8%，到分析期結束時規模將達到86億美元。全血細分市場在分析期間的複合年成長率預計為1.5%。

美國市場規模估計為 35 億美元，中國市場預期複合年成長率為 4.4%

預計2024年，美國血液及血液成分市場規模將達35億美元。作為世界第二大經濟體的中國，預計2030年市場規模將達到28億美元，在2024-2030年的分析期間內，複合年成長率為4.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為0.7%和1.7%。在歐洲，預計德國市場的複合年成長率為1.2%。

全球血液和血液成分市場—主要趨勢和促進因素摘要

為什麼整個醫療保健系統對血液和血液成分的需求不斷增加？

血液和血液成分在現代醫學中發揮著至關重要的作用，在外科手術、創傷護理、癌症治療、慢性病管理等領域發揮著挽救生命的治療作用。由於貧血、血友病、白血病和其他血液疾病的發生率不斷上升，全球對包括紅血球 (RBC)、血小板、血漿和凝血因子在內的血液製品的需求正在成長。此外，器官移植、複雜手術和積極化療等醫療程序的進步進一步增加了對穩定高效血液供應的需求。

輸血仍然是急診護理的基本組成部分，尤其是在應對意外事故、戰場傷勢和產婦分娩出血時。此外，人口老化加劇了血液相關疾病的易感性，這也加劇了人們對血液成分的依賴。儘管需求不斷成長，但挑戰依然存在，包括血液短缺、捐贈者數量不足以及對輸血傳染感染疾病(TTI) 的擔憂。為了解決這些問題，醫療機構、血庫和生技公司正在探索創新解決方案，包括合成血液替代品、病原體去活化技術和先進的血液儲存技術。

科技進步如何改善血液的採集、處理和儲存？

血液處理和輸血醫學領域的技術創新顯著提高了血液和血液成分的安全性、效率和可用性。其中最具影響力的進展之一是病原體去除技術 (PRT) 的開發，該技術可以去除血液製品中的病毒、細菌和寄生蟲，從而降低輸血傳播感染疾病的風險。這些處理方法，例如紫外線病原體去活化和溶劑-清潔劑等離子體處理，正在提高全球輸血的安全性。

可以選擇性地採集血漿、血小板和紅血球等特定血液成分，而將剩餘血液送回捐贈者體內。單採血液成分不僅提高了捐贈者的保留率，而且還透過減少全血捐血的需求提高了血液採集效率。此外，冷凍保存和長期血液儲存技術的進步解決了供應鏈挑戰並確保了血液成分的長期有效性，特別是在偏遠和災害多發地區。合成血液的持續發展，包括基於血紅蛋白的氧載體 (HBOC) 和基於全氟碳 (PFC) 的血液替代，為緊急輸血和軍事應用帶來了希望，有可能減少對捐捐血液供應的依賴。

哪些市場趨勢推動了血液和血液成分產業的發展？

由於疾病盛行率上升、外科手術增多、醫療基礎設施改善等因素，全球血液及血液成分市場正在擴張。影響該行業的最顯著趨勢之一是對血漿衍生療法的日益重視。血漿分餾已成為關鍵的投資領域，因為血漿衍生產品對於治療免疫力缺乏、血友病和神經系統疾病至關重要。對免疫球蛋白、白蛋白和凝血因子的需求不斷成長，促使生物製藥公司擴大其血漿採集網路並投資大型分離設施。

影響市場的另一個主要趨勢是自願和無償捐血政策的轉變。許多國家正在實施舉措，透過提高意識的宣傳活動、獎勵和數位參與策略來改善捐血者的招募和保留。此外，區塊鏈和數位追蹤系統在血液供應鏈中的整合正在提高透明度、減少浪費並改善血庫的可追溯性。個人化醫療和再生醫學的擴展也推動了人們對自體輸血的興趣，自體輸血是指在手術或癌症治療期間採集並回輸患者自身的血液。隨著醫療保健系統優先考慮效率和安全性，數位化血液管理解決方案和先進捐血者篩檢技術的採用有望進一步簡化血液的收集和分配。

影響血液和血液成分市場未來發展的關鍵成長動力有哪些？

血液及血液成分市場的成長受到多種關鍵因素的推動，包括慢性病負擔的加重、輸血醫學的進步以及對血液安全和供應鏈最佳化的投資不斷增加。其中一個主要成長要素是外科手術和創傷病例的增加，這些病例需要可靠的血液供應。隨著全球範圍內擇期手術和急診手術數量的增加，醫院和醫療保健機構正在投資血庫和輸血服務，以確保在關鍵手術期間有充足的血液供應。

影響市場的另一個關鍵促進因素是對血漿衍生療法不斷成長的需求。生物製藥產業專注於免疫力缺乏治療、血友病治療和新型血漿療法，這推動了血漿收集工作的增加和重組療法的研究。此外，採用先進的捐贈者篩檢技術，例如核酸檢測 (NAT) 和人工智慧風險評估模型，正在提高血液安全性並降低輸血相關併發症的發生率。隨著政府和醫療保健組織加強對捐血、處理和輸血實踐的法律規範，市場有望繼續擴張。隨著合成血液替代品、病原體去活化策略和數位健康整合的不斷創新，血液和血液成分產業的未來將由增強的安全性、效率和可及性來定義，從而確保全球患者獲得更好的治療效果。

部分

產品類型（血液成分、全血）、用途（貧血、創傷/手術、癌症治療、出血性疾病、其他）、最終用途（醫院、門診手術中心、其他）

受訪公司範例

• American Association of Blood Banks（AABB）
• American Red Cross
• Australian Red Cross
• Baxter International Inc.
• Beckman Coulter, Inc.
• Bio Products Laboratory（BPL）
• bioMerieux SA
• Cerus Corporation
• CSL Limited
• European Blood Alliance
• Fresenius SE & Co. KGaA
• Grifols, SA
• Haemonetics Corporation
• Hualan Biological Engineering Inc.
• Immucor, Inc.
• Indian Red Cross Society
• Kedrion Biopharma
• Maco Pharma International GmbH
• Mitsubishi Tanabe Pharma Corporation
• Octapharma AG
• South African National Blood Service
• Takeda Pharmaceutical Company Limited
• Teleflex Incorporated
• Terumo Corporation

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Blood and Blood Components Market to Reach US$14.8 Billion by 2030

The global market for Blood and Blood Components estimated at US$13.0 Billion in the year 2024, is expected to reach US$14.8 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Blood Components, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Whole Blood Type segment is estimated at 1.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 4.4% CAGR

The Blood and Blood Components market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Blood and Blood Components Market - Key Trends & Drivers Summarized

Why Is the Demand for Blood and Blood Components Increasing Across Healthcare Systems?

Blood and blood components play a critical role in modern medicine, serving as life-saving therapeutic products in surgeries, trauma care, cancer treatments, and chronic disease management. With the increasing prevalence of conditions such as anemia, hemophilia, leukemia, and other hematologic disorders, the global demand for blood products-including red blood cells (RBCs), platelets, plasma, and clotting factors-continues to rise. Additionally, advancements in medical procedures, including organ transplants, complex surgeries, and aggressive chemotherapy treatments, have further elevated the need for a stable and efficient blood supply.

Blood transfusion remains a fundamental component of emergency medicine, particularly in response to accidents, battlefield injuries, and maternal hemorrhage during childbirth. Moreover, the growing geriatric population, which is more susceptible to blood-related disorders, has contributed to an increasing reliance on blood components. Despite the rising demand, challenges such as blood shortages, donor recruitment, and concerns over transfusion-transmitted infections (TTIs) persist. To address these issues, healthcare organizations, blood banks, and biotech firms are exploring innovative solutions, including artificial blood substitutes, pathogen reduction technologies, and advanced blood storage techniques.

How Are Technological Advancements Enhancing Blood Collection, Processing, and Storage?

Innovations in blood processing and transfusion medicine are significantly improving the safety, efficiency, and availability of blood and blood components. One of the most impactful advancements is the development of pathogen reduction technologies (PRTs), which help eliminate viruses, bacteria, and parasites from blood products, reducing the risk of transfusion-transmitted infections. These technologies, including UV light-based pathogen inactivation and solvent-detergent plasma treatment, are enhancing the safety profile of blood transfusions worldwide.

Another breakthrough in the blood industry is the introduction of automated apheresis systems, which allow for the selective collection of specific blood components such as plasma, platelets, or red blood cells while returning the remaining blood to the donor. Apheresis not only improves donor retention but also increases the efficiency of blood collection by reducing the need for whole blood donations. Additionally, advancements in cryopreservation and extended blood storage techniques are addressing supply chain challenges, ensuring that blood components remain viable for longer durations, especially in remote or disaster-stricken regions. The ongoing development of synthetic blood substitutes, including hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon-based (PFC) blood substitutes, holds promise for emergency transfusions and military applications, potentially reducing dependency on donor blood supplies.

Which Market Trends Are Driving Growth in the Blood and Blood Components Industry?

The global blood and blood components market is expanding due to a combination of rising disease prevalence, increasing surgical procedures, and improvements in healthcare infrastructure. One of the most prominent trends shaping the industry is the growing emphasis on plasma-derived therapies. Plasma fractionation has become a key area of investment, as plasma-derived products are essential in treating immunodeficiency disorders, hemophilia, and neurological conditions. With rising demand for immunoglobulins, albumin, and clotting factors, biopharmaceutical companies are expanding plasma collection networks and investing in large-scale fractionation facilities.

Another key trend influencing the market is the shift toward voluntary and non-remunerated blood donation policies. Many countries are implementing initiatives to improve donor recruitment and retention through awareness campaigns, incentives, and digital engagement strategies. Additionally, the integration of blockchain and digital tracking systems in blood supply chains is enhancing transparency, reducing wastage, and improving traceability in blood banking. The expansion of personalized medicine and regenerative therapies is also driving interest in autologous blood transfusions, where a patient’s own blood is collected and reinfused during surgeries or cancer treatments. As healthcare systems prioritize efficiency and safety, the adoption of digital blood management solutions and advanced donor screening techniques is expected to further streamline blood collection and distribution.

What Are the Key Growth Drivers Shaping the Future of the Blood and Blood Components Market?

The growth in the blood and blood components market is driven by several critical factors, including the increasing burden of chronic diseases, advancements in transfusion medicine, and rising investments in blood safety and supply chain optimization. One of the primary growth drivers is the expanding number of surgical procedures and trauma cases, necessitating a reliable blood supply. With an increasing number of elective and emergency surgeries being performed worldwide, hospitals and healthcare providers are investing in blood banking and transfusion services to ensure availability during critical interventions.

Another crucial driver shaping the market is the growing demand for plasma-derived therapeutics. The biopharmaceutical industry’s focus on immunodeficiency treatments, hemophilia care, and novel plasma-based therapies has led to increased plasma collection efforts and research into recombinant alternatives. Additionally, the adoption of advanced donor screening technologies, including nucleic acid testing (NAT) and AI-driven risk assessment models, is improving blood safety and reducing the incidence of transfusion-related complications. As governments and healthcare organizations strengthen regulatory frameworks for blood donation, processing, and transfusion practices, the market is poised for continued expansion. With ongoing innovations in synthetic blood substitutes, pathogen reduction strategies, and digital health integration, the future of the blood and blood components industry will be defined by enhanced safety, efficiency, and accessibility, ensuring better patient outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Blood and Blood Components market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Blood Components, Whole Blood Type); Application (Anemia Application, Trauma and Surgery Application, Cancer Treatment Application, Bleeding Disorders Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgical Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• American Association of Blood Banks (AABB)
• American Red Cross
• Australian Red Cross
• Baxter International Inc.
• Beckman Coulter, Inc.
• Bio Products Laboratory (BPL)
• bioMerieux SA
• Cerus Corporation
• CSL Limited
• European Blood Alliance
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Haemonetics Corporation
• Hualan Biological Engineering Inc.
• Immucor, Inc.
• Indian Red Cross Society
• Kedrion Biopharma
• Maco Pharma International GmbH
• Mitsubishi Tanabe Pharma Corporation
• Octapharma AG
• South African National Blood Service
• Takeda Pharmaceutical Company Limited
• Teleflex Incorporated
• Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Blood and Blood Components - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Demand for Transfusion Therapies Throws the Spotlight on Blood and Blood Component Supply Chains
  • Growth in Surgical Procedures and Trauma Cases Drives Steady Demand for Red Blood Cells and Whole Blood Products
  • Expansion of Hematological and Oncology Treatments Strengthens the Business Case for Platelet and Plasma Component Utilization
  • Aging Population and Associated Chronic Diseases Fuel Long-Term Demand for Blood-Based Therapeutics
  • Increasing Use of Plasma-Derived Medicinal Products (PDMPs) Expands Addressable Market Opportunity for Plasma Collection and Processing
  • Technological Advancements in Apheresis and Component Separation Enhance Efficiency and Product Quality
  • Growing Awareness and Adoption of Patient Blood Management (PBM) Programs Spur Rational Use of Blood Components
  • Development of Recombinant and Synthetic Alternatives Creates a Balancing Dynamic in Blood Component Markets
  • Rise in Voluntary Blood Donation Campaigns Strengthens Public Health Infrastructure in Emerging Economies
  • Increasing Prevalence of Rare Blood Disorders and Autoimmune Conditions Generates Demand for Specialized Component Therapies
  • Integration of Pathogen Reduction Technologies (PRT) Enhances Safety and Shelf-Life of Blood Components
  • Growth of Cell Therapy and Regenerative Medicine Markets Opens New Avenues for Blood-Derived Cellular Components
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Blood and Blood Components Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Blood and Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Whole Blood Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Whole Blood Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Whole Blood Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Anemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Trauma & Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Trauma & Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Trauma & Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Cancer Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Cancer Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Cancer Treatment Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Bleeding Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Blood and Blood Components by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Blood and Blood Components by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Blood and Blood Components by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Blood and Blood Components by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION